Viridian Therapeutics (VRDN) – Market Summary
Trading Activity
- At 03:11 PM Central Europe on Friday, 23 November 2026, Viridian Therapeutics shares closed at USD 22.82, a decline of 0.83 % compared with the previous session.
- The stock is currently trading on major exchanges at a price of USD 22.82.
Volume and Market Capitalisation
- Total shares outstanding: 113.3 million.
- Market capitalisation: USD 2.6 billion.
- Net trading volume in the last 24 hours: USD 35.3 million worth of shares exchanged.
Price Performance
- Year‑to‑date change (since the close on 23 October 2026): +6.49 %.
- 200‑day simple moving average: USD 21.99.
- 52‑week high: USD 34.29 (recorded on 14 January 2026).
- 52‑week low: USD 13.18 (recorded on 29 April 2026).
Recent Performance of Peer Companies (24‑hour period)
| Symbol | Current Price | % Change | Market Cap (USD bn) | P/E Ratio |
|---|---|---|---|---|
| AVA (Avista) | 37.74 | +2.22 % | 3.1 | 13.36 |
| BSM (Black Stone Minerals) | 14.71 | +0.82 % | 3.1 | 12.23 |
| FOUR (Shift4 Payments) | 40.17 | –2.35 % | 3.1 | 60.46 |
| CPK (Chesapeake Utilities) | 134.17 | +3.27 % | 3.1 | 20.73 |
| BELFA (Bel Fuse) | 161.69 | –8.56 % | 3.1 | 43.16 |
Black Stone Minerals – Additional Notes Black Stone Minerals LP reported financial results for the year ended 30 June 2026. The company recorded a loss and continues to rely on equity‑based financing for exploration. Cash balances increased modestly, and the working‑capital position improved; however, an accumulated deficit remains significant. Management emphasized ongoing exploration expenditures and the need for further capital. No material changes were noted in the asset base or liability structure.
Company Overview – Viridian Therapeutics
Viridian Therapeutics, Inc. is a biotechnology firm focused on developing therapeutic candidates for thyroid eye disease (TED), an orphan disease. The company operates in the United States and maintains a presence through its website at www.viridiantherapeutics.com . Its shares are listed on the Nasdaq exchange.
